Harmony Biosciences Holdings Cash Flow Statement (2019-2026) | HRMY

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-9.62M22.71M21.48M23.53M87.94M48.51M29.48M34.30M38.46M26.61M38.33M11.59M46.09M49.48M45.56M39.78M50.87M65.26M32.49M73.68M
Depreciation and Depletion (Quarter)
0.10M0.12M0.12M0.09M0.10M0.11M0.10M0.10M0.14M0.16M0.16M0.09M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
4.66M4.38M4.90M7.37M6.97M6.94M7.20M7.79M7.96M10.39M10.96M59.80M-30.03M12.50M25.04M22.74M42.55M33.77M59.27M
Deferred Taxes (Quarter)
-4.26M-3.44M-4.19M-6.91M1.12M-3.48M-14.28M-4.83M-6.71M-4.31M-6.49M-3.88M7.38M-3.86M-3.20M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.39M0.39M0.27M0.48M0.37M0.43M0.46M0.51M0.47M0.66M0.49M0.48M0.47M0.47M-0.01M0.40M0.56M0.68M
Cash from Operations (Quarter)
30.42M37.53M28.85M33.73M55.20M26.68M42.56M37.06M63.10M76.67M31.14M42.62M70.50M75.56M33.99M79.33M108.73M126.15M27.76M92.43M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.64M0.68M0.72M0.68M0.59M0.63M0.55M0.49M0.45M0.45M0.34M0.28M0.22M0.42M
Amortization of Deferred Charges (Quarter)
0.46M0.42M0.41M0.41M0.42M0.42M0.42M0.42M
Depreciation & Amortization (CF) (Quarter)
0.10M0.12M0.12M0.09M0.10M0.11M0.10M0.10M0.14M0.16M0.16M0.09M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
2.01M1.64M3.29M11.69M5.24M-0.33M-2.17M11.24M3.45M6.88M5.58M3.44M-1.66M1.53M22.94M-12.99M7.67M-3.86M11.44M2.77M
Change in Inventory (Quarter)
-0.15M-0.37M0.17M-0.39M-0.31M0.40M-0.21M0.76M0.23M0.28M0.49M-0.21M1.27M0.28M-0.81M-0.28M0.78M-1.52M-0.08M1.08M
Change in Account Payables (Quarter)
2.17M-3.18M5.90M-0.24M3.39M-6.26M2.63M0.15M-0.02M6.20M-2.59M6.14M-12.15M3.21M3.71M10.84M-1.96M-8.65M10.91M-6.92M
Change in Accured Expenses (Quarter)
5.94M8.72M-3.59M8.99M37.76M-22.75M-1.85M3.14M14.42M30.77M-8.23M-16.87M24.32M12.57M-5.46M-7.03M28.03M52.45M-46.18M22.87M
Other Working Capital Changes (Quarter)
3.09M-2.06M2.23M1.47M1.00M2.84M-0.59M-1.64M3.99M-1.83M3.44M0.56M0.85M-1.84M2.00M3.59M-12.53M-24.84M3.00M7.85M
Investing Activities
Capital Expenditures (Quarter)
0.09M0.04M0.04M0.09M0.11M0.01M0.63M0.00M0.51M0.13M0.00M0.07M0.11M
Change in Acquisitions & Divestments (Quarter)
8.20M45.99M17.50M32.20M22.62M18.93M25.56M24.04M30.01M21.62M19.32M19.56M20.56M27.35M21.03M
Cash from Investing Activities (Quarter)
-0.09M-40.05M-22.45M-32.45M-46.90M-1.79M-7.77M-0.81M-36.06M-6.19M-54.86M0.74M-7.19M2.36M-19.59M-4.79M-17.63M-183.65M-131.50M
Financing Activities
Other financing activities (Quarter)
1.13M7.58M1.88M1.25M2.14M3.57M3.91M0.68M0.24M0.23M0.12M0.57M2.58M3.24M4.71M2.10M0.75M2.65M0.35M5.52M
Cash from Financing Activities (Quarter)
-0.31M7.07M1.38M0.75M2.05M2.66M3.41M-0.34M-55.10M-53.52M-3.63M-3.45M-1.18M-2.74M-0.35M-2.69M-3.00M-3.02M-7.22M-0.56M
Additional items
Change in Cash (Quarter)
30.02M44.60M-9.81M12.03M24.81M-17.56M44.18M28.95M7.19M-12.92M21.32M-15.69M70.07M65.63M36.00M57.05M100.95M105.50M-163.10M-39.63M
Free Cash Flow (Quarter)
30.33M37.53M28.81M33.69M55.12M26.68M42.56M37.06M63.10M76.56M31.14M41.98M70.50M75.05M33.86M79.32M108.66M126.04M27.76M92.43M
Net Cash Flow (Quarter)
30.02M44.60M-9.81M12.03M24.81M-17.56M44.18M28.95M7.19M-12.92M21.32M-15.69M70.07M65.63M36.00M57.05M100.95M105.50M-163.10M-39.63M